Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The role of the cerebrospinal fluid biomarkers in a tertiary memory clinic: our 4-year experience (CROSBI ID 543183)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | domaća recenzija

Boban, Marina ; Grbić, Kristina ; Mladinov, Mihovil ; Hof, Patrick ; Suessmair, Christine ; Ackl, Nibal ; Bader, Benedict ; Danek, Adrian ; Šimić, Goran The role of the cerebrospinal fluid biomarkers in a tertiary memory clinic: our 4-year experience // Neurologia Croatica. Supplement / Šimić, Goran ; Mimica, Ninoslav ; Petravić, Damir (ur.). 2008. str. 80-80

Podaci o odgovornosti

Boban, Marina ; Grbić, Kristina ; Mladinov, Mihovil ; Hof, Patrick ; Suessmair, Christine ; Ackl, Nibal ; Bader, Benedict ; Danek, Adrian ; Šimić, Goran

engleski

The role of the cerebrospinal fluid biomarkers in a tertiary memory clinic: our 4-year experience

Background: Alzheimer's disease (AD) is the most prevalent type of dementia. Although diagnostic markers for AD have been continuously improving, they still do not guarantee a definite diagnosis. However, it is safe to say that known biological markers from cerebrospinal fluid (CSF) can differentiate AD from other primary causes of dementia with high reliability and validity. As such, they were recently, together with structural and functional neuroimaging and genetic testing, included as an ancillary method in the clinical diagnostic criteria for AD. Objective: To assess the usability of CSF total tau protein (t-tau), tau protein phosphorylated at threonine 181 (p-tau-181) and beta-amyloid in a mixed population of patients with suspected dementia referred to a tertiary memory clinic. Patients and methods: Fifty-four consecutive patients with various primary causes of the dementia syndrome were included in the study. A retrospective diagnosis was established using the consensus criteria without prior knowledge of the CSF results. Lumbar puncture was performed as a part of the routine clinical workup. Levels of t-tau, p-tau-181 and beta-amyloid in CSF were measured using commercially available ELISA kits from Innogenetics, Ghent, Belgium and Biosource International, Camarillo, CA, USA. Results: Except for beta-amyloid, the overall sensitivity of the other two markers for diagnosis of AD was in range from 77 to 92%.

aging ; Alzheimer's disease ; cerebrospinal fluid ; cognition ; dementia ; diagnosis ; mild cognitive impairment ; tau proteins

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

80-80.

2008.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Neurologia Croatica. Supplement

Šimić, Goran ; Mimica, Ninoslav ; Petravić, Damir

Zagreb: Denona

1331-5196

Podaci o skupu

4th Croatian Congress on Alzheimer's disease with international participation

poster

08.10.2008-11.10.2008

Rovinj, Hrvatska

Povezanost rada

Temeljne medicinske znanosti, Kliničke medicinske znanosti, Psihologija